Gujarat Themis Biosyn Limited (GUJTHEM) reported revenue of ₹43.79 Cr and net profit of ₹11.07 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
GUJTHEM fundamentals, Fundamental score 75/100
The statements below are read from Gujarat Themis Biosyn Limited’s filed results, 11 filed quarters and 12 fiscal years on record, standalone basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Aug 8, 2026 · audited
Sales CAGR · 3Y+3.9%FY22 → FY25
Sales CAGR · 4Y+9.6%FY21 → FY25
PAT CAGR · 3Y−7.0%FY22 → FY25
PAT CAGR · 4Y+1.5%FY21 → FY25
Price · 1Y+7.9%EOD
Price CAGR · 3Y+66.5%EOD
Showing standalone — consolidated filings end Q1 FY26-27.
Quarterly resultsStandalone
₹ Cr
Jun2021
Mar2022
Jun2022
Dec2022
Sep2023
Dec2023
Mar2025
Sep2025
Dec2025
Mar2026
Jun2026Latest
YoYlatest
Sales
32.4
28.8
44.9
28.2
39.7
38.9
37.7
78.2
43.4
44.2
43.8
—
16.5
16.4
22.8
16.8
23.8
22.2
21.7
43.4
22.1
24.9
23.0
—
Operating profit
—
—
—
—
—
—
16.0
34.9
21.3
19.4
20.8
—
OPM %
—
—
—
—
—
—
42.5%
44.6%
49.1%
43.8%
47.5%
—
Other income
1.13
1.51
1.42
1.81
1.00
1.00
1.35
1.09
0.42
0.92
0.13
—
Interest
—
—
—
—
—
—
0.07
0.08
0.96
1.91
1.79
—
Depreciation
—
—
—
—
—
—
1.23
4.99
3.89
4.04
3.97
—
Profit before tax
17.1
13.9
23.6
13.2
16.9
17.7
16.1
30.9
16.9
14.3
15.2
—
Tax %
24.5%
29.4%
24.6%
25.6%
25.7%
26.5%
25.4%
24.5%
26.1%
24.0%
27.0%
—
Net profit
12.9
9.79
17.8
9.81
12.5
13.0
12.0
23.3
12.5
10.9
11.1
—
EPS (₹)
—
—
—
—
—
—
1.10
1.31
1.14
0.00
1.02
—
One column per filed quarter · ₹ crore · YoY = latest vs the same quarter a year back · EPS restated for bonus/split↔ scroll for earlier quarters
Revenue & net profit trend
last 11 quarters
RevenueNet profit
Revenue & net profit — Standalone11 quarters
Segment results
Needs segment dataSegment results not parsedPer-segment revenue, EBIT margin and YoY arrive once we parse the segment annexure from the filing.
Forensic checksauto-scanned from the filing
Coming soonForensic checks not connectedAuditor opinion, OCF÷PAT, contingent liabilities, related-party share and working-capital days arrive as we parse the notes-to-accounts + cash-flow statement. Promoter-pledge is already on the Holdings tab.
How results moved the priceEOD reaction on the session the market could trade the filing
Avg absolute result-day move ±2.7%· EPS surprise: no estimates source· 6 earlier quarters have no dated filing on record
Q1'27filed Fri 7 Aug 13:12 · traded that sessiongap +0.8%close −1.6%
Q4'26filed Mon 25 May 15:14 · traded that sessiongap +2.8%close +5.6%
Q3'26filed Thu 5 Feb 18:54 · first tradeable session Fri 6 Febgap −1.0%close −1.4%
Q2'26filed Mon 10 Nov 16:18 · first tradeable session Tue 11 Novgap +2.0%close −0.8%
Q4'25filed Tue 20 May 20:36 · first tradeable session Wed 21 Maygap −8.2%close −3.8%
